Method for the prevention or reduction of cariovascular...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/24 (2006.01) A61K 31/196 (2006.01)

Patent

CA 2361581

This invention provides a method for the prevention or reduction of cardiovascular events associated with coronary intervention in a mammal, particularly a human, which comprises administering to the subject N-(3',4'- dimethoxycinnamoyl)anthranilic acid (N-5') or a pharmaceutically acceptable salt thereof in a daily dose of from greater than 300 mg to about 1,200 mg for a treatment period of up to 89 days in association with coronary intervention.

L'invention concerne une méthode de prévention ou réduction d'incidents cardio-vasculaires associés à une intervention coronarienne, chez un mammifère, notamment chez l'homme, cette méthode consistant à administrer à ce sujet un acide N-(3',4'-diméthoxycinnamoyl)anthranilique (N-5') ou un sel de celui-ci, acceptable sur le plan pharmacologique, en dose quotidienne comprise entre une quantité supérieure à 300 mg et environ 1200 mg, pendant une période pouvant couvrir jusqu'à 89 jours, en relation avec l'intervention coronarienne.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method for the prevention or reduction of cariovascular... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the prevention or reduction of cariovascular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the prevention or reduction of cariovascular... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1984613

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.